| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919009 | Radiotherapy and Oncology | 2011 | 7 Pages |
Abstract
Tobacco smoking among prostate-cancer survivors treated with radiotherapy increases the risk of certain long-lasting symptoms from the bowel and anal-sphincter region.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David Alsadius, Maria Hedelin, Karl-Axel Johansson, Niclas Pettersson, Ulrica Wilderäng, Dan Lundstedt, Gunnar Steineck,